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Human epidermal keratinocytes were cultured until sub-confluence in low Ca2+ (0.15 mM) serum-free synthetic MCDB 153 medium. Raising the 
Ca*+ concentration to 1.15 mM caused an increase in envelope competence as well as plasma membrane associated transglutaminase (TGm) activi- 
ty. This increase was not observed when the high Ca2+ medium contained retinoic acid. Immunofluorescence studies as well as immunoblotting 
with the TGm-specific monoclonal antibody B.Cl revealed that retinoic acid inhibits expression of TGm. Isolation and in vitro translation of 
mRNA with subsequent immunoprecipitation showed that retinoic acid inhibits TGm expression at the pretranslational level. 
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1. INTRODUCTION 
Cultured normal human keratinocytes are able to ex- 
press two types of transglutaminase, the cytosoluble, 
ubiquitous tissue type (TGc) and a plasma membrane 
associated enzyme (TGm) found in the epidermis and 
other stratifying epithelia [ 1,2]. TGm is responsible for 
the synthesis of the cornified envelope in terminally dif- 
ferentiating keratinocytes [ 1,3-61. Appearance of 
TGm, and thus envelope formation is suppressed in the 
presence of retinoic acid [3,4,7,8] whereas under the 
same conditions TGc is either not affected (in normal 
human keratinocytes [7]) or even strongly stimulated (in 
many other cell types [9,10]). 
Even though TGc and TGm have different im- 
munoreactivities and biochemical properties 121, both 
enzymes catalyse protein cross-linking upon Ca’ + ac- 
tivation giving rise to distinct envelope like structures in 
cultured keratinocytes [111. It has been speculated very 
often, but never proven unequivocally that retinoic acid 
acts by inhibiting the de novo synthesis of TGm rather 
than by preventing a post-translational modification - 
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one which may, for example, be necessary for the an- 
chorage of the enzyme in the plasma membrane [12]. 
In the present paper we show by in vitro translation 
of human keratinocyte mRNA and subsequent im- 
munoprecipitation with the TGm-specific monoclonal 
antibody B.Cl that retinoic acid controls the expression 
of this enzyme at the pre-translational level. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
The MCDB 153 culture medium and bovine pituatary extract were 
obtained from Clonetics Corporation, San Diego. The other media 
and fetal calf serum were from Flow Laboratories and GIBCO. 
[“Slmethionine and EN3HANCE were from New England Nuclear. 
Poly(U) Sepharose was purchased from Pharmacia LKB 
Biotechnology Inc. and the reticulocyte lysate was supplied by Pro- 
mega Biotec. The TGm-specific monoclonal antibody B.Cl was rais- 
ed against he particulate transglutaminase and a generous gift of Dr. 
S. Thacher, A&M College, Texas. 
2.2. Cells and culture conditions 
Keratinocytes from normal human foreskin were cultured until 
sub-confluence in low calcium MCDB 153 basal medium (0.15 mM 
Ca*+), containing 5 mg insulin and 10rg EGF per liter. This com- 
pletely defined medium was supplemented with 0.4% bovine pituitary 
extract. Upon reaching sub-confluence, the cultures were exposed for 
6 days to the above medium containing high Ca* + (1.15 mM) in the 
presence and absence of 3 PM retinoic acid. The medium was changed 
every second day. 
2.3. Isolation of poiy(A ‘) RNA, in vitro translation and immuno- 
precipitation 
Total RNA was isolated using the guanidine monothiocyanate x- 
traction procedure of Cathala et al. [13]. Poly(A+) RNA was pre- 
pared with poly(U) Sepharose according to [14]. Aliquots (1 fig) of the 
mRNA were translated in reticulocyte lysates using [“Slmethio- 
nine as a tracer. The translation products were immunoprecipitated 
with the TGm-specific B.Cl monoclonal antibody. The culture 
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Table 1 
Transglutaminase activity and A 23187 ionophore induced envelope 
formationa 
Conditions TGm activityb Envelope synthesis 
0.15 mM Ca*+ , 
no retinoic acid 
0.15 mM Ca2+ 
+ retinoic acid 
1.15 mM Ca*‘, 
no retinoic acid 
1.15 mM Ca*+ 
+ retinoic acid 
4.3 10% 
0.9 0% 
47 75% 
5.2 10% 
aTGm activity and envelope competence were determined as described 
in [3] 
bSpecific activity is expressed in nmol putrescine bound to 
dimethylcasein per mg protein per h, at 37°C 
medium of the myeloma cell line SPzO was used as a control. The im- 
munoprecipitates were analysed by SDS gel electrophoresis. 
2.4. Electrophoresis and immunoblotting 
Epidermal TGm was extracted from keratinocytes by homogeniz- 
ing the cells in a 20 mM Tris-HCl buffer, pH 7.5, containing 150 mM 
NaCl, 1 mM EDTA, 1% Nonidet-P40 and 10 pg/ml aprotinin, 1 
pg/ml chymostatin, 0.1 mM phenyl methyl sulfonyl fluoride as pro- 
tease inhibitors. SDS polyacrylamide gel electrophoresis was carried 
out under reducing conditions as described [15]. A 10% acrylamide 
gel was used and 75 pg protein were routinely applied to each slot. 
For immunoblotting experiments, the proteins were transferred to 
nitrocellulose paper as described [ 161. The sheets were saturated for 
1.5 hat room temperature in 10 mM Tris-HCI, pH 7.4, containing 140 
mM NaCl and 3% (w/v) bovine serum albumin. They were incubated 
with the monoclonal antibody B.Cl or with SP20 control superna- 
tant. The sheets were washed and incubated with ‘251-labeled anti- 
mouse Ig F(ab’)z fragment (0.25 mCi/ml). After washing they were 
exposed for autoradiography to a Kodak XAR-5 film with a DuPont 
Cronex intensifying screen. 
Analysis of the immunoprecipitates was performed on 10% SDS 
polyacrylamide gels. Fluorography was performed by treating the gels 
with EN’HANCE. The dried gels were exposed to Kodak XAR-5 
films. 
2.5. Indirect immunofjuorescence staining 
Immunofluorescence staining was performed as recently described 
[2]. Cells were fixed and permeabilized with methanol at - 20°C for 
10 min. After washing with PBS, they were incubated either with 
B.Cl monoclonal antibody supernatant or with SPzO supernatant and 
with fluorescein-conjugated goat anti-mouse IgG (diluted 1:lOO in 
PBS). 
3. RESULTS AND DISCUSSION 
The shift of sub-confluent normal human epidermal 
keratinocytes from 0.15 mM Ca* + to medium contain- 
ing l.lSmMCa*+, caused, within 6 days, a remarkable 
increase in TGm activity. Furthermore, 75% of the cells 
developed envelope competence, i.e. they synthesized 
cornified envelopes after ionophore induction. 
Fig. 1. 
36 
lmmunofluorescence staining with the TGm-specific monoclonal antibody B.Cl of control (A) and retinoic acid-treated (B) hum 
keratinocytes 6 days after the shift to high Ca*+ (1.15 mM). 
ran 
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Fig.2. lmmunoblot with the TGm-specific monclonal antibody B.Cl 
after electrophoretic separation of detergent soluble proteins (75 
~gllane) of control (lane A) and retinoic acid treated (lane B) human 
keratinocytes. Lane C shows the result obtained with the SPzO control 
Fig.3. Electrophoretic analysis of proteins obtained after 
immunoprecipitation with either SPzO supernatant (lanes A and C) or 
the TGm-specific monoclonal antibody B.Cl (lanes B and D) of the 
in vitro translation products of mRNA isolated from control (lanes A 
and B) or retinoic acid treated (lanes C and D) human keratinocytes. 
The arrow indicates position of TGm and lane E presents the 
supernatant . molecular weight markers. 
However, when the high Ca2 + medium contained 3 FM 
retinoic acid, TGm activity did not increase and only 
10% of the cells were envelope competent. These results 
are summarized in table 1. 
Immunofluorescence studies using the TGm-specific 
monoclonal antibody B.Cl, revealed the virtual 
absence of any labeling in retinoic acid treated ceils, 
whereas the plasma membranes of control cells were in- 
tensively stained (fig.lA to be compared with fig.lB). 
To exclude the possibility that in retinoic acid treated 
cells, masking of TGm accounted for this finding, a 
detergent soluble protein extract was prepared from 
control and retinoic acid treated cells as described in 
Materials and Methods. The immunoblots obtained 
after electrophoretic separation of these proteins reveal- 
ed the presence of a substantial amount of TGm in con- 
trol cells, whereas TGm was hardly detectable in ex- 
tracts obtained from retinoic acid treated cells (fig.2, 
lane A to be compared with lane B). 
The above results obtained by immunofluorescence 
staining and immunoblotting indicate that retinoic acid 
does not interfere with the TGm-activity but rather in- 
hibits expression of this enzyme. 
To find out at which level retinoic acid affects TGm 
expression, mRNA from control and retinoic acid- 
treated cells was purified and translated in vitro in 
reticulocyte lysates. The translation products were im- 
munoprecipitated with the TGm-specific B.Cl mono- 
clonal antibody and electrophoretically separated. Fig.3 
- 97.5 
-67 
-45 
-30 
shows that he control cells but not the retinoic acid- 
treated cells contained translatable mRNA coding for 
TGm (lane B to be compared with lane D). 
From these results we conclude that retinoic acid in- 
terferes at the pre-translational level, very likely by in- 
hibiting transcription of the TGm gene. The effect of 
retinoic acid is most probably mediated by the recently 
described nuclear retinoic acid receptors f 17-201. 
However, other retinoic acid induced mechanisms that 
involve premature termination of the transcription pro- 
cess or the degradation of mRNA [21,22] cannot be ex- 
cluded. 
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